Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis
{{output}}
Background: Generalized pustular psoriasis (GPP) is a rare, life-threatening disease attributed to aberrant interleukin-36 (IL-36) activity, often due to variants in the IL-36 receptor antagonist gene. Imsidolimab is a novel, hum... ...
